Novonesis is a leading global biosolutions company, formed through the merger of Novozymes and Chr. Hansen. With a focus on transforming production, consumption, and sustainability, Novonesis leverages biological solutions to address challenges in industries such as food, beverages, health, agriculture, and environmental protection. Their products range from probiotics to enzymes and functional proteins, contributing to healthier food systems, improved human and animal health, and reduced environmental impact. With over 10, 000 employees worldwide, Novonesis is at the forefront of innovation in biological sciences.